These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25473945)

  • 1. Prospective evaluation of teleophthalmology in screening and recurrence monitoring of neovascular age-related macular degeneration: a randomized clinical trial.
    Li B; Powell AM; Hooper PL; Sheidow TG
    JAMA Ophthalmol; 2015 Mar; 133(3):276-82. PubMed ID: 25473945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration.
    Thomas M; Wolfson Y; Zayit-Soudry S; Bressler SB; Bressler NM
    JAMA Ophthalmol; 2015 Dec; 133(12):1425-30. PubMed ID: 26468999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography.
    Jackson TL; Dugel PU; Bebchuk JD; Smith KR; Petrarca R; Slakter JS; Jaffe GJ; Nau JA;
    Ophthalmology; 2013 Aug; 120(8):1597-603. PubMed ID: 23490325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial.
    Kodjikian L; Souied EH; Mimoun G; Mauget-Faÿsse M; Behar-Cohen F; Decullier E; Huot L; Aulagner G;
    Ophthalmology; 2013 Nov; 120(11):2300-9. PubMed ID: 23916488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optometric referrals to retina specialists: evaluation and triage via teleophthalmology.
    Hanson C; Tennant MT; Rudnisky CJ
    Telemed J E Health; 2008 Jun; 14(5):441-5. PubMed ID: 18578678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab for neovascular age-related macular degeneration in China.
    Li X; Hu Y; Sun X; Zhang J; Zhang M;
    Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
    Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
    Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.
    Holekamp NM; Liu Y; Yeh WS; Chia Y; Kiss S; Almony A; Kowalski JW
    Am J Ophthalmol; 2014 Apr; 157(4):825-833.e1. PubMed ID: 24388973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
    Bloch SB
    Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the siRNA PF-04523655 versus ranibizumab for the treatment of neovascular age-related macular degeneration (MONET Study).
    Nguyen QD; Schachar RA; Nduaka CI; Sperling M; Klamerus KJ; Chi-Burris K; Yan E; Paggiarino DA; Rosenblatt I; Aitchison R; Erlich SS;
    Ophthalmology; 2012 Sep; 119(9):1867-73. PubMed ID: 22683252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.
    Do DV; Gower EW; Cassard SD; Boyer D; Bressler NM; Bressler SB; Heier JS; Jefferys JL; Singerman LJ; Solomon SD
    Ophthalmology; 2012 Apr; 119(4):771-8. PubMed ID: 22297028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
    Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U
    Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiological study of neovascular age-related macular degeneration in Germany.
    Krause L; Yousif T; Pohl K;
    Curr Med Res Opin; 2013 Oct; 29(10):1391-7. PubMed ID: 23944372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study.
    Prenner JL; Halperin LS; Rycroft C; Hogue S; Williams Liu Z; Seibert R
    Am J Ophthalmol; 2015 Oct; 160(4):725-31.e1. PubMed ID: 26142721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration.
    Kumar N; Mrejen S; Fung AT; Marsiglia M; Loh BK; Spaide RF
    Ophthalmology; 2013 Feb; 120(2):334-41. PubMed ID: 23137630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of photographic screening for neovascular age-related macular degeneration.
    Maberley DA; Isbister C; Mackenzie P; Aralar A
    Eye (Lond); 2005 Jun; 19(6):611-6. PubMed ID: 15184945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual acuity and central retinal thickness: fulfilment of retreatment criteria for recurrent neovascular AMD in routine clinical care.
    Reznicek L; Muhr J; Ulbig M; Kampik A; Mayer WJ; Haritoglou C; Neubauer A; Wolf A
    Br J Ophthalmol; 2014 Oct; 98(10):1333-7. PubMed ID: 24903670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.